Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Changgui Li and Runxiang Long.
Changgui Li
Connection Strength
0.180
Runxiang Long
  1. Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults. Clin Infect Dis. 2021 12 06; 73(11):e3949-e3955.
    View in: PubMed
    Score: 0.061
  2. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Mol Ther Methods Clin Dev. 2021 Dec 10; 23:108-118.
    View in: PubMed
    Score: 0.060
  3. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 05 12; 39(20):2746-2754.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.